Abstract 2589: Investigations of covalent binding efficiency for third-generation EGFR irreversible inhibitors AZD9291 and CO-1686
Zhen Qin(Qingdao University of Science and Technology), Lusong Luo(BeiGene (China)), Yunguang Du(BeiGene (China)), Ye Liu(Southeast University), Miao Wang(Zhejiang Chinese Medical University), Min Wei(Southwest University of Science and Technology), Jiye Zhang(Xi'an Jiaotong University), Hao Peng(BeiGene (China)), Xuebing Sun(BeiGene (China)), Nan Hu(BeiGene (China)), Lai Wang(Arog Pharmaceuticals (United States))
Cited by 1
Related Papers
Mice carrying a knock-in mutation of Aicda resulting in a defect in somatic hypermutation have impaired gut homeostasis and compromised mucosal defense
|Nature Immunology|2011|257
Small molecule selenium-containing compounds: Recent development and therapeutic applications
|European Journal of Medicinal Chemistry|2021|233
Butyrate enhances CPT1A activity to promote fatty acid oxidation and iTreg differentiation
|Proceedings of the National Academy of Sciences|2021|182